SHARE THIS VIDEO —

FDA panel promotes misinformation about antidepressants during pregnancy

NBC News medical contributor Dr. Natalie Azar reports on the FDA panel discussion of the use of antidepressants during pregnancy. The panel shared misinformation and facts taken out of context, according to several psychiatrists who tuned in to the meeting. Medical professionals say the risk of untreated depression far outweighs the potential risks of the medication to mother and child.